Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Aug;112(8):1147-57.
doi: 10.1016/j.jand.2012.05.008.

Biophysiologic outcomes of the Enhancing Adherence in Type 2 Diabetes (ENHANCE) trial

Mary Ann Sevick  1 , Mary Korytkowski, Roslyn A Stone, Beth Piraino, Dianxu Ren, Susan Sereika, Yuanyuan Wang, Ann Steenkiste, Lora E Burke
Affiliations
Randomized Controlled Trial

Biophysiologic outcomes of the Enhancing Adherence in Type 2 Diabetes (ENHANCE) trial

Mary Ann Sevick et al. J Acad Nutr Diet. 2012 Aug.

Abstract

Background: Behavioral research to improve lifestyle in broadly defined populations of patients with type 2 diabetes is limited.

Objective: We evaluated a behavioral intervention featuring technology-based self-monitoring on biophysiologic outcomes of glycemic control and markers of cardiovascular risk.

Design: In this single-site, randomized clinical trial, participants were stratified by good and poor glycemic control (glycated hemoglobin <8% or ≥8%) and absence or presence of kidney disease, (estimated glomerular filtration rate ≥60 or <60 mL/min) and randomized within strata. Measurements were obtained at 0, 3, and 6 months.

Participants/setting: Self-referred, community-dwelling adults with type 2 diabetes mellitus.

Intervention: The intervention group received Social Cognitive Theory-based counseling paired with technology-based self-monitoring, and results were compared with an attention control group.

Main outcome measures: Glycated hemoglobin, fasting serum glucose, lipid levels, blood pressure, weight, body mass index, and waist circumference were evaluated.

Statistical analyses performed: Mean differences within and between randomization groups were compared over time. Intervention effects over time were estimated using random intercept models.

Results: Two hundred ninety-six subjects were randomized, 256 (86.5%) completed 3-month and 246 (83.1%) completed 6-month assessments. Glycated hemoglobin was reduced in the intervention group by 0.5% at 3 months and 0.6% at 6 months (P<0.001 for each), and the control group by 0.3% (P<0.001) at 3 months and 0.2% (P<0.05) at 6 months; but between-group differences were not significant. In those with baseline glycated hemoglobin ≥8% and estimated glomerular filtration rate ≥60 mL/min, glycated hemoglobin was reduced in the intervention group by 1.5% at 3 months and 1.8% at 6 months (P<0.001 for each), and the control group by 0.9% (P<0.001) at 3 months and 0.8% (P<0.05) at 6 months; but between-group differences were not significant. In random intercept models, the estimated reduction in glycated hemoglobin of 0.29% was not significant.

Conclusions: Two behavioral approaches to improving general lifestyle management in individuals with type 2 diabetes mellitus were effective in improving glycemic control, but no significant between-group differences were observed.

Trial registration: ClinicalTrials.gov NCT00222846.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of ENHANCE Study screening, enrollment, randomization, and follow-up.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention . National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; Atlanta, GA: 2011.
    1. United States Renal Data System . USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda: 2009.
    1. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet. 2010;375(9731):2073–2081. - PMC - PubMed
    1. Bello AK, Hemmelgarn B, Lloyd A, et al. Associations among Estimated Glomerular Filtration Rate, Proteinuria, and Adverse Cardiovascular Outcomes. Clin J Am Soc Nephrol. 2011;6(6):1418–1426. - PMC - PubMed
    1. American Diabetes Association Standard of Medical Care in Diabetes – 2011. Diabetes Care. 2011;34(suppl 1):S11–S61. - PMC - PubMed

Publication types

MeSH terms

Associated data